News
Rapid7 (RPD) Beats Q2 Earnings and Revenue Estimates
Rapid7 (RPD) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.58 per share a year ago. These figures are
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
Nektar Therapeutics (NKTR) came out with a quarterly loss of $2.95 per share versus the Zacks Consensus Estimate of a loss of $3.13. This compares to a loss of $3.75 per share a year ago. These
Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Amphastar Pharmaceuticals (AMPH) reported revenue of $174.41 million, down 4.4% over the same period last year. EPS came in at $0.85, compared to $0.94 in the
Akamai Technologies (AKAM) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Akamai Technologies (AKAM) reported revenue of $1.04 billion, up 6.5% over the same period last year. EPS came in at $1.73, compared to $1.58 in the year-ago
Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates
Gen Digital (GEN) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.53 per share a year ago. These figures
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
Doximity (DOCS) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.28 per share a year ago. These figures
AudioEye (AEYE) Q2 Earnings and Revenues Miss Estimates
AudioEye (AEYE) came out with quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.12 per share a year ago. These figures
PTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates
PTC Therapeutics (PTCT) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $1.16 per share a year ago. These figures
Nerdy Inc. (NRDY) Reports Q2 Loss, Lags Revenue Estimates
Nerdy Inc. (NRDY) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.08 per share a year ago. These figures are
Monster Beverage (MNST) Tops Q2 Earnings and Revenue Estimates
Monster Beverage (MNST) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.41 per share a year ago. These
Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates
Turtle Beach (TBCH) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.3 per share a year ago. These figures are
Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates
Solventum (SOLV) came out with quarterly earnings of $1.69 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.56 per share a year ago. These figures
Consensus Cloud Solutions, Inc. (CCSI) Q2 Earnings and Revenues Top Estimates
Consensus Cloud Solutions, Inc. (CCSI) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.45 per share a
CytomX Therapeutics (CTMX) Reports Break-Even Earnings for Q2
CytomX Therapeutics (CTMX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.08 per share a year ago. These
EOG Resources (EOG) Surpasses Q2 Earnings and Revenue Estimates
EOG Resources (EOG) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $3.16 per share a year ago. These
HireQuest, Inc. (HQI) Q2 Earnings and Revenues Top Estimates
HireQuest, Inc. (HQI) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.15 per share a year ago. These
Maplebear (CART) Q2 Earnings and Revenues Beat Estimates
Maplebear (CART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.2 per share a year ago. These figures
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates
Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $0.51 per share a year ago
GoDaddy (GDDY) Q2 Earnings and Revenues Top Estimates
GoDaddy (GDDY) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.1 per share a year ago. These figures are
GigaCloud Technology Inc. (GCT) Q2 Earnings and Revenues Surpass Estimates
GigaCloud Technology Inc. (GCT) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.65 per share a year ago
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.08 per share a year ago. These figures
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
BioLife Solutions, Inc. (BLFS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.06 per share a year ago. These
Akamai Technologies (AKAM) Surpasses Q2 Earnings and Revenue Estimates
Akamai Technologies (AKAM) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.58 per share a year ago
Clipper Realty Inc. (CLPR) Beats Q2 FFO Estimates
Clipper Realty Inc. (CLPR) came out with quarterly funds from operations (FFO) of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to FFO of $0.17 per share a
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.94 per share a year


